Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI (Author`s Reply)

Kaynakça (2)

1. Kaymaz C, Keleş N, Özdemir N, Tanboğa İH, Demircan HC, Can MM, et al. The effects of tirofiban infusion on clinical and angiographic out-comes of patients with STEMI undergoing primary PCI. Anatol J Cardiol 2014 Dec 25. Epub ahead of print
2. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al; Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarc-tion in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619. [CrossRef] 3. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, et al. Facilitated PCI in patients with ST-elevation myocardial infarc-tion. N Engl J Med 2008; 358: 2205-17. [CrossRef] 4. Jeremias A, Vasu S, Gruberg L, Kastrati A, Stone GW, Brown DL. Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stent-ing. Catheter Cardiovasc Interv 2010; 75: 895-902. [CrossRef] 5. Mrdovic I, Savic L, Lasica R, Krljanac G, Asanin M, Brdar N, et al. Efficacy and safety of tirofiban-supported primary percutaneous coro-nary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register. Eur Heart J Acute Cardiovasc Care 2014; 3: 56-66. [CrossRef] 6. Zhu J, Zhang T, Xie Q, Zhang J. Effects of upstream administration of tirofiban before percutaneous coronary intervention on spontaneous reperfusion and clinical outcomes in acute ST-segment elevation myo-cardial infarction. Angiology 2015; 66: 70-8. [CrossRef]